These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 2609846

  • 41. Effect of long-term administration of buflomedil on regional cerebral blood flow in chronic cerebral infarction.
    Kobayashi S, Yamaguchi S, Okada K, Kitani M, Yamashita K, Shimote K, Tsunematsu T.
    Angiology; 1988 Nov; 39(11):934-41. PubMed ID: 3177960
    [Abstract] [Full Text] [Related]

  • 42. Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency.
    Demichelis Genesio MA, Sanz MC.
    Angiology; 1981 Oct; 32(10):717-28. PubMed ID: 7034593
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G, Rotatori P, Gaggi S, Barone A, Pupita F.
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract] [Full Text] [Related]

  • 45. [Study of carotid flow and cerebral circulatory impedance using Doppler computerized spectral analysis. Evaluation of the effect of buflomedil].
    Scondotto G, De Fabritiis A, Caniato A, Pili C, Borgatti E.
    Minerva Cardioangiol; 1986 Nov; 34(11):751-8. PubMed ID: 3543731
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. [Buflomedil in arterial occlusive disease. Results of a controlled study].
    Trübestein G, Balzer K, Bisler H, Klüken N, Mahfoud Y, Müller-Wiefel H, Unkel B, Ziegler W.
    Dtsch Med Wochenschr; 1982 Dec 24; 107(51-52):1957-61. PubMed ID: 6756854
    [No Abstract] [Full Text] [Related]

  • 48. [Acute affect of buflomedil hydrochloride (bufedil) on transcutaneously measured oxygen pressures in patients with peripheral arterial occlusive disease].
    Lemke R, Klaus D.
    Vasa; 1984 Dec 24; 13(2):171-4. PubMed ID: 6741240
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Oral buflomedil in diabetic background retinopathy: results of a preliminary controlled study.
    Ducrey N, Curchod B.
    J Int Med Res; 1984 Dec 24; 12(3):184-7. PubMed ID: 6734921
    [Abstract] [Full Text] [Related]

  • 51. Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
    Bachir D, Maurel A, Beuzard Y, Razavian M, Kraiem A, Portos JL, Galacteros F.
    Microvasc Res; 1993 Nov 24; 46(3):359-73. PubMed ID: 8121319
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Action and tolerability of delayed-action buflomedil in obliterating arteriopathies of the lower limbs. A multicenter study].
    Andreozzi GM, Lepore R.
    Clin Ter; 1990 Nov 30; 135(4):273-81. PubMed ID: 2150026
    [Abstract] [Full Text] [Related]

  • 54. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
    Clissold SP, Lynch S, Sorkin EM.
    Drugs; 1987 May 30; 33(5):430-60. PubMed ID: 3297620
    [Abstract] [Full Text] [Related]

  • 55. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001 May 30; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Effectiveness of buflomedil in arterial occlusive disease. Modification of transcutaneous oxygen pressure in a placebo-controlled double-blind study].
    Sunder-Plassmann L, Gandolfo AM, Utz C.
    MMW Munch Med Wochenschr; 1984 Mar 02; 126(9):247-8. PubMed ID: 6425678
    [No Abstract] [Full Text] [Related]

  • 60. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S, Pieragalli D, Acciavatti A, Del Bigo C, Galigani C, Ralli L, Guerrini M, Di Perri T.
    J Int Med Res; 1984 Mar 02; 12(3):188-92. PubMed ID: 6734922
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.